Technology

Control Bionics Limited (ASX:CBL)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Equipment & Supplies

Market Price : AUD 0.635-0.035 (5.224%)

(as on 2021-09-26 10:27:24)

Market Cap : AUD 53.051 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.67 0.64 0.635 0.635L 0.645 H 0.52L 1.24 H
Last Trade 0.635
Change% -5.2239
52 W H/L 1.24/0.52
EBITDA 0
NPAT After Abnormal Items -3.551 M
Equity 17.163 M
ROE% -20.69%
Total Liabilities 1.19 M
Total Revenue 4.429 M
Cash and Cash Equivalents 12.331 M

Stock Information

Share price 0.635
Market Cap 53.051 M
Price/Gross Cash Flow -25.93
Dividend Yield Excluding Special 0.00%
Ending Shares 83.514 M
52-Week Range 0.52-1.24
P/E ratio 0.000
Sector P/E --
EPS -5.66
EV/EBITDA --
Net Profit Margin (%) -90.38%
Gross Cash Flows Per Share -0.04
Net Gearing -71.76%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.16
Sales Per Share 0.06
Book Value Per Share 0.21

Announcements

Heading Date/Time
Amended Change of Director's Interest Notice - Phillips  22/09/2021 2:46PM
Change of Director's Interest Notice - Phillips  22/09/2021 1:28PM
Letter to shareholders re 2021 AGM  13/09/2021 4:21PM
Notice of Annual General Meeting/Proxy Form  13/09/2021 4:18PM
Notification regarding unquoted securities - CBL  01/09/2021 3:44PM
Application for quotation of securities - CBL  27/08/2021 12:02PM
Appendix 4E  26/08/2021 10:42AM
Appendix 4G  26/08/2021 9:04AM
Corporate Governance Statement  26/08/2021 9:03AM
2021 Annual Report  26/08/2021 9:03AM
Cleansing notice  11/08/2021 3:30PM
Application for quotation of securities - CBL  11/08/2021 3:28PM
Release of shares from escrow  09/08/2021 3:14PM
Monthly Activities/Appendix 4C Cash Flow Report  27/07/2021 11:55AM
Reseller agreement with DNR Wheels - Singapore  27/07/2021 10:55AM
Cleansing statement  25/05/2021 4:01PM
Appendix 2A  25/05/2021 3:59PM
Appendix 4C - Quarterly  28/04/2021 10:03AM
Appendix 2A - Release from mandatory escrow  19/04/2021 11:45AM
Reseller agreement with Numotion - US  07/04/2021 8:41AM
Release of shares from escrow  06/04/2021 8:16AM
Change of Director's Interest Notice - Lismore  22/03/2021 8:16AM
Becoming a substantial holder  08/03/2021 11:17AM
Half Year Results Investor Presentation  25/02/2021 10:28AM
Half year results commentary  25/02/2021 10:27AM
Half Yearly Report and Accounts  25/02/2021 10:24AM
Release of shares from voluntary escrow  23/02/2021 10:54AM
Release of half year results and webinar  23/02/2021 8:55AM
Section 708A(5)(e) Notice  15/02/2021 6:34PM

Similar Companies

Related Articles

About Company

Control Bionics (ASX: CBL) is an assistive technology company that provides Electromyography or EMG-based wearable bionic devices. It serves people with disabilities that have a negative impact on their verbal communication. The company’s products help users to communicate via computer using intentional thought and the body’s own neuroelectric signals which are detected at skeletal level. Founded in 2005 by Peter Ford, Control Bionics has also introduced the NeuroNode, an EMG assistive technology device.

Corporate Information

company address Suite G.03, 171 Union Road Surrey Hills, Surrey Hills, SURREY HILLS, VIC, AUSTRALIA, 3127

company phone+61 3 9897 3576

company websitehttps://www.controlbionics.com/

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 --

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-25 2022
Report (Prelim) 2022-08-25 2022
Report (Interim) 2022-02-24 2022

Financials

Breakdown 30/06/2021 30/06/2020
Trading Revenue 3.929 M --
Other Revenue 500,319 0
Total Revenue 4.429 M 0
Interest Income 1,161 0
Interest Expenses -70,376 0
Expenses -7.712 M 0
EBITDA -3.283 M 0
Depreciation and Amortization -198,534 0
Depreciation -187,513 0
Amortisation -11,021 0
EBIT -3.482 M 0
Pre Tax Profit -3.551 M 0
Tax Expense 0 0
Net Profit After Tax -3.551 M 0
Minority Interest 0 0
Preference Dividend 0 0
Net Abnormal Items 0 0
Reported Net Profit After Abnormal Items -3.551 M 0
Ending Shares 83.514 M 83.333 M
Weighted Average Shares 62.693 M 83.333 M
EPS After Abnormal Items (cents) -5.66 0
Breakdown 30/06/2021 30/06/2020
Total Current Assets 13.721 M 16.092 M
Total Non Current Assets 4.632 M 4.421 M
Total Assets 18.353 M 20.513 M
Total Current Liabilities 1.173 M 364,000
Total Non Current Liabilities 16,857 23,000
Total Liabilities 1.19 M 387,000
Net Assets 17.163 M 20.126 M
Breakdown 30/06/2021 30/06/2020
Net Operating Cash -3.991 M 0
Net Invested Cash -53,398 0
Net Financing Cash Flows 14.923 M 0
End Cash Position 12.331 M 0
Beginning Cash 1.428 M 0
Exchange Rate Adjustments 24,180 0
Other Cash Adjustments 0 0
Ending Cash 12.331 M 0

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ) at www.morningstar.com.au/s/fsg.pdf and www.morningstar.com.au/s/fapds.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under license from ASX Operations Pty Ltd ACN 004 523 782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK